Pollen Allergy Market

Pollen Allergy Market Size and Share Forecast Outlook (2023 to 2033)

The global pollen allergy market is currently valued at USD 5850.8 Million in 2023 and is anticipated to expand at a CAGR of 4.2%. Owing to the technological advances in healthcare the market is likely to propel to USD 8828.6 Million by 2033.

The rising prevalence of allergic disorders and their burden across the globe are likely to drive the growth of the pollen allergy market in the forecast period.

Report Attribute	Details
Expected Market Value (2023)	USD 5850.8 Million
Projected Forecast Value (2033)	USD 8828.6 Million
Global Growth Rate (2023 to 2033)	4.2% CAGR

Comparison of 2018 to 2022 Revenue vs 2023 to 2033 Demand Forecast for Pollen Allergy Treatments

The pollen allergy market is expected to gain market growth in the forecast period of 2023 to 2033. Latest market analysis by FMI the market is to grow at a CAGR of 4.2% in the above-mentioned forecast period.

Pollens are referred to as mostly consist of tiny particles released by grasses, trees, and plants during their reproductive cycle. These pollen particles can easily gasp by animals and humans which can cause inflammation and irritation to some individuals and this allergy can lead to fever and rhinitis.

Patients with pollen allergy need to be aware of the changes that can occur in their area to help them adapt to changes in the pattern and presentation of disease that may result from climate change. The global pollen allergy market rose at a CAGR of 3.8% from 2018 to 2022.

Key Trends Influencing the Pollen Allergy Industry

The rising Prevalence of Allergy and Changing Lifestyle Leading to Decreased Immune Resistance drive the Pollen Allergy Market

The rise in the number of patients suffering from pollen-based allergies and more precisely hay fever drives the growth of the market. Moreover, the growing number of patients especially children is another contributor to escalating the global pollen allergy market. Rapid urbanization in the advancing countries is the major factor that boosts the growth of the pollen allergies market in the forecast period.

Allergy is considered a risk factor for asthma, chronic inflammatory conditions and reduce quality of life. Because of these factors, there is a high need for the treatment of allergies. The global pollen allergy market is expected to show tremendous growth due to increased Pharmaceutical Research and Development spending and biotechnology investment.

The increase in greenhouse gas can result in pollen-induced reparative disease which is further estimated to cushion the growth of the pollen allergies market. Increasing environmental pollution will further provide opportunities for the growth of the pollen allergies market in the coming years.

Increase in Healthcare Spending and Government Initiatives to Drive the Market Growth

Over the past few decades, it has been noted that global per capita healthcare spending has increased considerably owing to the increasing rate of awareness regarding the availability of myriad treatments and diagnostic methods for treating various diseases.

Increasing healthcare spending is likely to result in increasing demand for better quality and rapid diagnostic methods, and in turn, create high growth opportunities for players operating in the treatment of pollen allergies market.

Respiratory disease places a huge burden on society in terms of disability and premature mortality, and also in direct health service costs, drugs prescribed, and the indirect costs related to lost production. Pollen allergy is frequently accompanied by allergic asthma treatment. This condition is also impacting the global pollen allergy market.

In order to increase awareness about allergic rhinitis, several government organizations have started awareness programs. For instance, Allergy UK is the operational name of the British Allergy Foundation that observes allergy awareness week from April 25 to May 1.

Challenges Restraining Growth in the Pollen Allergy Market

Increased Awareness Regarding Allergy Immunotherapy to Hamper the Market Growth

Despite a positive growth trajectory, the global pollen allergy market is facing various challenges that are likely to pose a threat to its growth during the forecast period.

The lack of a permanent cure for grass pollen allergy disease and home-based diagnosis are a few restraints to the growth of the global pollen allergy market. The rise in the preference towards the utilization of biosimilars is further projected to impede the growth of the pollen allergies market in the forecast period.

However, the decrease in the awareness of allergy immunotherapy (AIT) amongst patients might further challenge the growth of the pollen allergies market in the near future

Analysis of Top Countries Driving Pollen Allergy Diagnosis and Treatment

What Makes the USA an Attractive Market for Pollen Allergy?

Increasing Rate of Allergic Diseases in the USA to Propel the Market Growth

The USA is estimated to account for over 40% of the North American market in 2023. North America has dominated the global pollen allergy market due to the increased incidence rate of allergies and awareness of therapy.

A study conducted by the American College of Allergy, Asthma & Immunology in 2010 reported that about 16.9 million adults and 6.7 million children were diagnosed with hay fever and its prevalence is increasing by approximately 30% in adults and 40% in children.

The United States Food and Drug Administration 2014 estimated around 30 million people in the United States and 500 million globally suffer from one or other form of hay fever symptoms.

Moreover, the increasing focus on Research and Development to develop novel products to cater to high unmet medical needs is highly impacting the market’s growth.

For instance, GlaxoSmithKline plc announced that the USA Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No. 1 prescribed allergy treatment ingredient1, as an over-the-counter (OTC) treatment for temporary relief of the symptoms of hay fever or upper respiratory allergies.2

Why is the Pollen Allergy Market in Europe Expected to Be Highly Opportunistic?

Rising Prevalence of Respiratory Allergic Disorders Driving Growth in the Europe Market

The Europe pollen allergy market is expected to rise at a CAGR of 4.0% from 2023 to 2033. Europe is expected to have the second-largest market for global pollen allergy market. Increasing awareness among people about diseases is also a major factor that may boost the growth of the market in this region.

Europe dominates the pollen allergies market due to the rise in the prevalence of respiratory allergic disorders. Europe is the fastest-growing market in pollen allergy due to increasing healthcare funding by the government. Moreover, an increase in the need for therapeutics is further anticipated to propel the growth pollen allergies market in the region in the coming years.

The Charity Allergy UK estimated that about 18 million people were found to be affected with grass pollen allergy which is more common among children and teenagers. Symptoms of pollen include frequent sneezing, running or blocked nose, and itchy eyes, and throat. In some instances, it can also lead to loss of senses to smell, facial pain, sweating, and severe headache. People suffering from asthma face even worse symptoms which include tight chest, shortness of breath, coughing, and wheezing.

Which Factors Are Supporting Growth of the Pollen Allergy Market in Asia Pacific?

Advancement in Healthcare to Propel the Market Growth

Asia Pacific is anticipated to expand at the fastest CAGR of 3.8% during the forecast period. Asia Pacific emerged as the fastest-growing region in the pollen allergy market owing to the presence of unmet healthcare infrastructure needs and the increasing prevalence of allergic diseases.

Furthermore, favorable government initiatives in regions like Japan and Australia pertaining to drug price adjustment and the development of novel drugs for the treatment of pollen allergy are expected to provide manufacturers with lucrative future growth opportunities.

Country-wise Forecast CAGRs for the Pollen Allergy Market

Country	CAGR
The UK	4.0%
India	3.7%
South Korea	3.6%
China	3.8%
The USA	4.2%

Pollen Allergy Industry Analysis by Top Investment Segments

Based on the therapeutic drug class, Which Is the Most Prominent Segment in The Pollen Allergy Market?

Corticosteroids Segment Remains Dominant Among Other Types

Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy are the key segments analyzed in the scope of the study.

Corticosteroids dominated the pollen allergy market in 2023 with a revenue share of 35.5%. Corticosteroids are mostly used as the first line of treatment and are also expected to contribute towards the aforementioned conclusion.

Whereas, calcineurin inhibitors are expected to grow at the fastest CAGR during the forecast period owing to their high response rate and the presence of a strong pipeline of calcineurin inhibitors and semi-synthetic analogs of these inhibitors.

By allergen Type, Which Segment Generates High Revenue in Pollen Allergy Market?

Inhaled Allergen SignificantlyDominated the Market

Based on allergen type, the market is categorized into food, inhaled, drug, and others. Inhaled allergens led the global pollen allergy market in 2023 due to increased incidences of respiratory allergies across the globe. The segment is projected to expand further at the fastest CAGR owing to the high demand for allergy testing and the introduction of specific allergens for the detection of pollen allergy.

The drug allergies segment is also expected to register a strong CAGR of 3.8% from 2023 to 2033. Food allergies were the second-largest segment, in terms of revenue share, and are projected to continue the trend throughout the forecast years. Children are more susceptible to these types of allergic diseases. According to the estimates published by the USA National Institute of Health (NIH), the prevalence of food allergies among children is double that of adults.

Emerging Start-up Landscape in the Pollen Allergy Sector

How do New Entrants Contribute to the Pollen Allergy Market?

With technological innovations happening at a rapid pace, and companies looking for ways to increase customer engagement, start-ups are taking all possible steps to establish a name for themselves in the pollen allergy market.

Some of the start-ups in the pollen allergy market include-

• Allergie is a provider of an app for allergy detection. It provides an Allergohelp app that helps users to reduce allergic symptoms to avoid allergy triggers. The app offers pollen count or pollen flight forecast data along with pollen types. It also provides a symptom tracker that helps to document symptoms anytime and anywhere and collect information for diagnosis or treatment.
• Pollen Sense- the world’s only automated sensor network providing live pollen and mold counts!
• Smart Pollen Monitoring provides an app to manage pollen allergies for patients. The company offers a 3D-based application platform that helps in simulating the pollen in the environment and gives predictive insights for the users. The platform also features the routing ability to track directions without any harmful pollen stimulants and tree blooming statistical data to predict the growth and quantity of pollen in the air.

Competitive Outlook for the Pollen Allergy Market

The professional survey study carefully analyses the operations and overview of the corporate structures and functioning of the leading and major manufacturers and players functional within the global pollen allergy market. It assesses its product offerings, financial outlook, sales, revenue, and growth over the forecast period.

Some of the leading manufacturers and players assessed in the global pollen allergy market are bioMerieux SA, HOB Biotech Group Corp Ltd, Alcon, HYCOR Biomedical, Inc, Immunomic Therapeutics, Quest Diagnostics Incorporated, Omega Diagnostics Group PLC, Siemens Healthcare Private Limited, Stallergenes Greer, Lincoln Diagnostics, Inc., and others

Manufacturers and players functional in the pollen allergy market are adopting various corporate growth strategies such as new product launches, mergers and acquisitions, and geographical expansion, among others.

• In January 2022, Stallergenes Greer, a global healthcare company specializing in allergen immunotherapy (AIT), announced that the company has entered into a research collaboration on the discovery of biomarkers of AIT efficacy with Imperial College London, a global top ten university with a world-class reputation in science, engineering, business, and medicine.
• BioMérieux and NecstGen collaborated to accelerate the development of Cell and Gene Therapies (CGT) through the provision of ‘state of the art’ and rapid quality and safety testing technologies that will allow safe and effective advanced therapeutics production.
• Astellas Pharma Inc. and Immunomic Therapeutics, Inc. announced that the USA Food and Drug Administration (FDA) has granted Fast Track designation for the drug candidate ASP0892 for the mitigation of severe hypersensitivity reactions due to peanut allergy. ASP0892 is a new DNA vaccine program based on the investigational LAMP-Vax platform. A Phase I clinical trial to evaluate the safety, tolerability, and immune response of ASP0892 in adults allergic to peanuts has been initiated.

Scope of the Pollen Allergy Market Report

Report Attribute	Details
Growth Rate	CAGR 4.2% from 2023 to 2033
Expected Market Value (2023)	USD 5850.8 Million
ProjectedForecast Value (2033)	USD 8828.6 Million
Base Year for Estimation	2022
Historical Data	2018 to 2022
Forecast Period	2023 to 2033
Quantitative Units	Revenue in USD Million & CAGR from 2023 to 2033
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive L&scape, Growth Factors, Trends & Pricing Analysis
Segments Covered	Product Type, Allergen Type, Therapeutics Drug Class, End-User, Regions
Regions Covered	North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East & Africa (MEA)
Key Countries Profiled	The USA, Canada, Brazil, Mexico, Germany, The UK, France, Spain, Italy, India, Malaysia, Singapore, Thailand, Australia, New Zealand, China, Japan, South Korea, GCC, South Africa, Israel
Key Companies Profiled	bioMerieux SA; HOB Biotech Group Corp Ltd; Alcon; HYCOR Biomedical, Inc; Immunomic Therapeutics; Quest Diagnostics Incorporated; Omega Diagnostics Group PLC; Siemens Healthcare Private Limited; Stallergenes Greer; Lincoln Diagnostics, Inc.
Customization	Available Upon Request

Table of Content

• 1. Executive Summary | Pollen Allergy Market
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
• 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
  • 5.1. Instruments
  • 5.2. Consumables
  • 5.3. Services
• 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Allergen Type
  • 6.1. Food
  • 6.2. Inhaled
  • 6.3. Drug
  • 6.4. Others
• 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapeutics Drug Class
  • 7.1. Antihistamines
  • 7.2. Decongestants
  • 7.3. Corticosteroids
  • 7.4. Mast Cell Stabilizers
  • 7.5. Leukotriene Inhibitors
  • 7.6. Nasal Anticholinergics
  • 7.7. Immunomodulators
  • 7.8. Auto-injectable Epinephrine
  • 7.9. Immunotherapy
• 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
  • 8.1. Diagnostic Laboratories
  • 8.2. Hospitals
  • 8.3. Academic Research Institutes
• 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
  • 9.1. North America
  • 9.2. Latin America
  • 9.3. Europe
  • 9.4. South Asia
  • 9.5. East Asia
  • 9.6. Oceania
  • 9.7. Middle East & Africa (MEA)
• 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 17. Key Countries Market Analysis
• 18. Market Structure Analysis
• 19. Competition Analysis
  • 19.1. bioMerieux SA
  • 19.2. HOB Biotech Group Corp Ltd
  • 19.3. Alcon
  • 19.4. HYCOR Biomedical, Inc.
  • 19.5. Immunomic Therapeutics
  • 19.6. Quest Diagnostics Incorporated
  • 19.7. Omega Diagnostics Group PLC
  • 19.8. Siemens Healthcare Private Limited
  • 19.9. Stallergenes Greer
  • 19.10. Lincoln Diagnostics, Inc.
• 20. Assumptions & Acronyms Used
• 21. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Allergen Type, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by Therapeutics Drug Class, 2018 to 2033

Table 5: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by Allergen Type, 2018 to 2033

Table 9: North America Market Value (US$ Million) Forecast by Therapeutics Drug Class, 2018 to 2033

Table 10: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 13: Latin America Market Value (US$ Million) Forecast by Allergen Type, 2018 to 2033

Table 14: Latin America Market Value (US$ Million) Forecast by Therapeutics Drug Class, 2018 to 2033

Table 15: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 17: Europe Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 18: Europe Market Value (US$ Million) Forecast by Allergen Type, 2018 to 2033

Table 19: Europe Market Value (US$ Million) Forecast by Therapeutics Drug Class, 2018 to 2033

Table 20: Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 21: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: South Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 23: South Asia Market Value (US$ Million) Forecast by Allergen Type, 2018 to 2033

Table 24: South Asia Market Value (US$ Million) Forecast by Therapeutics Drug Class, 2018 to 2033

Table 25: South Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 26: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 27: East Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 28: East Asia Market Value (US$ Million) Forecast by Allergen Type, 2018 to 2033

Table 29: East Asia Market Value (US$ Million) Forecast by Therapeutics Drug Class, 2018 to 2033

Table 30: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 31: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 32: Oceania Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 33: Oceania Market Value (US$ Million) Forecast by Allergen Type, 2018 to 2033

Table 34: Oceania Market Value (US$ Million) Forecast by Therapeutics Drug Class, 2018 to 2033

Table 35: Oceania Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 36: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 37: MEA Market Value (US$ Million) Forecast by Product, 2018 to 2033

Table 38: MEA Market Value (US$ Million) Forecast by Allergen Type, 2018 to 2033

Table 39: MEA Market Value (US$ Million) Forecast by Therapeutics Drug Class, 2018 to 2033

Table 40: MEA Market Value (US$ Million) Forecast by End User, 2018 to 2033

List of Figures

Figure 1: Global Market Value (US$ Million) by Product, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Allergen Type, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Therapeutics Drug Class, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by End User, 2023 to 2033

Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 9: Global Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 10: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 11: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 12: Global Market Value (US$ Million) Analysis by Allergen Type, 2018 to 2033

Figure 13: Global Market Value Share (%) and BPS Analysis by Allergen Type, 2023 to 2033

Figure 14: Global Market Y-o-Y Growth (%) Projections by Allergen Type, 2023 to 2033

Figure 15: Global Market Value (US$ Million) Analysis by Therapeutics Drug Class, 2018 to 2033

Figure 16: Global Market Value Share (%) and BPS Analysis by Therapeutics Drug Class, 2023 to 2033

Figure 17: Global Market Y-o-Y Growth (%) Projections by Therapeutics Drug Class, 2023 to 2033

Figure 18: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 21: Global Market Attractiveness by Product, 2023 to 2033

Figure 22: Global Market Attractiveness by Allergen Type, 2023 to 2033

Figure 23: Global Market Attractiveness by Therapeutics Drug Class, 2023 to 2033

Figure 24: Global Market Attractiveness by End User, 2023 to 2033

Figure 25: Global Market Attractiveness by Region, 2023 to 2033

Figure 26: North America Market Value (US$ Million) by Product, 2023 to 2033

Figure 27: North America Market Value (US$ Million) by Allergen Type, 2023 to 2033

Figure 28: North America Market Value (US$ Million) by Therapeutics Drug Class, 2023 to 2033

Figure 29: North America Market Value (US$ Million) by End User, 2023 to 2033

Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 37: North America Market Value (US$ Million) Analysis by Allergen Type, 2018 to 2033

Figure 38: North America Market Value Share (%) and BPS Analysis by Allergen Type, 2023 to 2033

Figure 39: North America Market Y-o-Y Growth (%) Projections by Allergen Type, 2023 to 2033

Figure 40: North America Market Value (US$ Million) Analysis by Therapeutics Drug Class, 2018 to 2033

Figure 41: North America Market Value Share (%) and BPS Analysis by Therapeutics Drug Class, 2023 to 2033

Figure 42: North America Market Y-o-Y Growth (%) Projections by Therapeutics Drug Class, 2023 to 2033

Figure 43: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 46: North America Market Attractiveness by Product, 2023 to 2033

Figure 47: North America Market Attractiveness by Allergen Type, 2023 to 2033

Figure 48: North America Market Attractiveness by Therapeutics Drug Class, 2023 to 2033

Figure 49: North America Market Attractiveness by End User, 2023 to 2033

Figure 50: North America Market Attractiveness by Country, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) by Product, 2023 to 2033

Figure 52: Latin America Market Value (US$ Million) by Allergen Type, 2023 to 2033

Figure 53: Latin America Market Value (US$ Million) by Therapeutics Drug Class, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) by End User, 2023 to 2033

Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 59: Latin America Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 60: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 62: Latin America Market Value (US$ Million) Analysis by Allergen Type, 2018 to 2033

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Allergen Type, 2023 to 2033

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Allergen Type, 2023 to 2033

Figure 65: Latin America Market Value (US$ Million) Analysis by Therapeutics Drug Class, 2018 to 2033

Figure 66: Latin America Market Value Share (%) and BPS Analysis by Therapeutics Drug Class, 2023 to 2033

Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Therapeutics Drug Class, 2023 to 2033

Figure 68: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 71: Latin America Market Attractiveness by Product, 2023 to 2033

Figure 72: Latin America Market Attractiveness by Allergen Type, 2023 to 2033

Figure 73: Latin America Market Attractiveness by Therapeutics Drug Class, 2023 to 2033

Figure 74: Latin America Market Attractiveness by End User, 2023 to 2033

Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 76: Europe Market Value (US$ Million) by Product, 2023 to 2033

Figure 77: Europe Market Value (US$ Million) by Allergen Type, 2023 to 2033

Figure 78: Europe Market Value (US$ Million) by Therapeutics Drug Class, 2023 to 2033

Figure 79: Europe Market Value (US$ Million) by End User, 2023 to 2033

Figure 80: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 84: Europe Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 85: Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 86: Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 87: Europe Market Value (US$ Million) Analysis by Allergen Type, 2018 to 2033

Figure 88: Europe Market Value Share (%) and BPS Analysis by Allergen Type, 2023 to 2033

Figure 89: Europe Market Y-o-Y Growth (%) Projections by Allergen Type, 2023 to 2033

Figure 90: Europe Market Value (US$ Million) Analysis by Therapeutics Drug Class, 2018 to 2033

Figure 91: Europe Market Value Share (%) and BPS Analysis by Therapeutics Drug Class, 2023 to 2033

Figure 92: Europe Market Y-o-Y Growth (%) Projections by Therapeutics Drug Class, 2023 to 2033

Figure 93: Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 96: Europe Market Attractiveness by Product, 2023 to 2033

Figure 97: Europe Market Attractiveness by Allergen Type, 2023 to 2033

Figure 98: Europe Market Attractiveness by Therapeutics Drug Class, 2023 to 2033

Figure 99: Europe Market Attractiveness by End User, 2023 to 2033

Figure 100: Europe Market Attractiveness by Country, 2023 to 2033

Figure 101: South Asia Market Value (US$ Million) by Product, 2023 to 2033

Figure 102: South Asia Market Value (US$ Million) by Allergen Type, 2023 to 2033

Figure 103: South Asia Market Value (US$ Million) by Therapeutics Drug Class, 2023 to 2033

Figure 104: South Asia Market Value (US$ Million) by End User, 2023 to 2033

Figure 105: South Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 106: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 107: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 108: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 109: South Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 110: South Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 111: South Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 112: South Asia Market Value (US$ Million) Analysis by Allergen Type, 2018 to 2033

Figure 113: South Asia Market Value Share (%) and BPS Analysis by Allergen Type, 2023 to 2033

Figure 114: South Asia Market Y-o-Y Growth (%) Projections by Allergen Type, 2023 to 2033

Figure 115: South Asia Market Value (US$ Million) Analysis by Therapeutics Drug Class, 2018 to 2033

Figure 116: South Asia Market Value Share (%) and BPS Analysis by Therapeutics Drug Class, 2023 to 2033

Figure 117: South Asia Market Y-o-Y Growth (%) Projections by Therapeutics Drug Class, 2023 to 2033

Figure 118: South Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 119: South Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 120: South Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 121: South Asia Market Attractiveness by Product, 2023 to 2033

Figure 122: South Asia Market Attractiveness by Allergen Type, 2023 to 2033

Figure 123: South Asia Market Attractiveness by Therapeutics Drug Class, 2023 to 2033

Figure 124: South Asia Market Attractiveness by End User, 2023 to 2033

Figure 125: South Asia Market Attractiveness by Country, 2023 to 2033

Figure 126: East Asia Market Value (US$ Million) by Product, 2023 to 2033

Figure 127: East Asia Market Value (US$ Million) by Allergen Type, 2023 to 2033

Figure 128: East Asia Market Value (US$ Million) by Therapeutics Drug Class, 2023 to 2033

Figure 129: East Asia Market Value (US$ Million) by End User, 2023 to 2033

Figure 130: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 131: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 132: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 134: East Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 135: East Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 137: East Asia Market Value (US$ Million) Analysis by Allergen Type, 2018 to 2033

Figure 138: East Asia Market Value Share (%) and BPS Analysis by Allergen Type, 2023 to 2033

Figure 139: East Asia Market Y-o-Y Growth (%) Projections by Allergen Type, 2023 to 2033

Figure 140: East Asia Market Value (US$ Million) Analysis by Therapeutics Drug Class, 2018 to 2033

Figure 141: East Asia Market Value Share (%) and BPS Analysis by Therapeutics Drug Class, 2023 to 2033

Figure 142: East Asia Market Y-o-Y Growth (%) Projections by Therapeutics Drug Class, 2023 to 2033

Figure 143: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 144: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 145: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 146: East Asia Market Attractiveness by Product, 2023 to 2033

Figure 147: East Asia Market Attractiveness by Allergen Type, 2023 to 2033

Figure 148: East Asia Market Attractiveness by Therapeutics Drug Class, 2023 to 2033

Figure 149: East Asia Market Attractiveness by End User, 2023 to 2033

Figure 150: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 151: Oceania Market Value (US$ Million) by Product, 2023 to 2033

Figure 152: Oceania Market Value (US$ Million) by Allergen Type, 2023 to 2033

Figure 153: Oceania Market Value (US$ Million) by Therapeutics Drug Class, 2023 to 2033

Figure 154: Oceania Market Value (US$ Million) by End User, 2023 to 2033

Figure 155: Oceania Market Value (US$ Million) by Country, 2023 to 2033

Figure 156: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 157: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 158: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 159: Oceania Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 160: Oceania Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 161: Oceania Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 162: Oceania Market Value (US$ Million) Analysis by Allergen Type, 2018 to 2033

Figure 163: Oceania Market Value Share (%) and BPS Analysis by Allergen Type, 2023 to 2033

Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Allergen Type, 2023 to 2033

Figure 165: Oceania Market Value (US$ Million) Analysis by Therapeutics Drug Class, 2018 to 2033

Figure 166: Oceania Market Value Share (%) and BPS Analysis by Therapeutics Drug Class, 2023 to 2033

Figure 167: Oceania Market Y-o-Y Growth (%) Projections by Therapeutics Drug Class, 2023 to 2033

Figure 168: Oceania Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 169: Oceania Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 170: Oceania Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 171: Oceania Market Attractiveness by Product, 2023 to 2033

Figure 172: Oceania Market Attractiveness by Allergen Type, 2023 to 2033

Figure 173: Oceania Market Attractiveness by Therapeutics Drug Class, 2023 to 2033

Figure 174: Oceania Market Attractiveness by End User, 2023 to 2033

Figure 175: Oceania Market Attractiveness by Country, 2023 to 2033

Figure 176: MEA Market Value (US$ Million) by Product, 2023 to 2033

Figure 177: MEA Market Value (US$ Million) by Allergen Type, 2023 to 2033

Figure 178: MEA Market Value (US$ Million) by Therapeutics Drug Class, 2023 to 2033

Figure 179: MEA Market Value (US$ Million) by End User, 2023 to 2033

Figure 180: MEA Market Value (US$ Million) by Country, 2023 to 2033

Figure 181: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 184: MEA Market Value (US$ Million) Analysis by Product, 2018 to 2033

Figure 185: MEA Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 186: MEA Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 187: MEA Market Value (US$ Million) Analysis by Allergen Type, 2018 to 2033

Figure 188: MEA Market Value Share (%) and BPS Analysis by Allergen Type, 2023 to 2033

Figure 189: MEA Market Y-o-Y Growth (%) Projections by Allergen Type, 2023 to 2033

Figure 190: MEA Market Value (US$ Million) Analysis by Therapeutics Drug Class, 2018 to 2033

Figure 191: MEA Market Value Share (%) and BPS Analysis by Therapeutics Drug Class, 2023 to 2033

Figure 192: MEA Market Y-o-Y Growth (%) Projections by Therapeutics Drug Class, 2023 to 2033

Figure 193: MEA Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 194: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 195: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 196: MEA Market Attractiveness by Product, 2023 to 2033

Figure 197: MEA Market Attractiveness by Allergen Type, 2023 to 2033

Figure 198: MEA Market Attractiveness by Therapeutics Drug Class, 2023 to 2033

Figure 199: MEA Market Attractiveness by End User, 2023 to 2033

Figure 200: MEA Market Attractiveness by Country, 2023 to 2033